Evidence map›Paper›PMID 38400139›Full record

ReviewVaccines2024

Maysa Santos Barbosa, Beatriz Almeida Sampaio, Joachim Spergser, Renate Rosengarten, Lucas Miranda Marques, Rohini Chopra-Dewasthaly

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Maysa Santos BarbosaDepartment of Biointeraction, Multidisciplinary Institute of Health, Federal University of Bahia, Vitoria da Conquista 45029-094, Brazil.ORCID 0000-0003-2126-1202
Beatriz Almeida SampaioDepartment of Microbiology, State University of Santa Cruz (UESC), Ilheus 45662-900, Brazil.ORCID 0000-0002-2103-5945
Joachim SpergserInstitute of Microbiology, Department of Pathobiology, University of Veterinary Medicine Vienna, 1210 Wien, Austria.ORCID 0000-0002-0164-0179
Renate RosengartenInstitute of Microbiology, Department of Pathobiology, University of Veterinary Medicine Vienna, 1210 Wien, Austria.
Lucas Miranda MarquesDepartment of Biointeraction, Multidisciplinary Institute of Health, Federal University of Bahia, Vitoria da Conquista 45029-094, Brazil.ORCID 0000-0002-8276-8149
Rohini Chopra-DewasthalyInstitute of Microbiology, Department of Pathobiology, University of Veterinary Medicine Vienna, 1210 Wien, Austria.ORCID 0000-0002-6768-1256
University of Veterinary Medicine Vienna · ATUniversidade Federal da Bahia · BRUniversidade Estadual de Santa Cruz · BR

Funding

Austrian Science Fund (FWF) P18668-B05, P21796-B20 and P23595-B20
6 · The paper itself

Abstract

Contagious agalactia (CA) is a serious multietiological disease whose classic etiological agent is

Indexed as

antigenic variationcontagious agalactiaMycoplasma agalactiaesurface proteinsvaccine

Identifiers

PMID38400139
PMCPMC10892753
OpenAlexW4391470510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.